Combined Treatment With a Transforming Growth Factor Beta Inhibitor (1D11) and Bortezomib Improves Bone Architecture in a Mouse Model of Myeloma-Induced Bone Disease

Bone - Netherlands
doi 10.1016/j.bone.2016.07.007

Related search